InvestorsHub Logo
Followers 24
Posts 1479
Boards Moderated 0
Alias Born 10/05/2015

Re: None

Thursday, 08/08/2019 4:42:36 PM

Thursday, August 08, 2019 4:42:36 PM

Post# of 1518
Opiant Pharmaceuticals (NASDAQ:OPNT): Q2 EPS of $0.31 may not be comparable to consensus of -$0.55.

Revenue of $6.78M (+115.2% Y/Y) beats by $2.77M.